San Diego-based Modular Medical develops the MODD1 90-day insulin patch pump for adult “almost-pumpers.” It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.
MODD1’s new intuitive design makes the product simple to use and easier to prescribe. MODD1 earned FDA clearance for MODD1 in September 2024.
Now, the company said it took the next step toward scaling production for its pump cartridge. In a news release, Modular Medical called this capability a key differentiator in the pump space. It cited higher volumes needed for patch pump systems. The company says it designed its simple, low-cost platform from the ground up for high-volume manufacturing.
“This is an important milestone for scaling up our manufacturing infrastructure to support our commercial pilot for MODD1 and, eventually, our 3ml Pivot tubeless patch pump launch,” stated Jeb Besser, CEO of Modular Medical. “While we encountered significant delays with the initial shipment of equipment for the manufacturing line to our contract manufacturing site in Mexico, all equipment for the controller line has been installed and validation is underway. We continue to target controller line validation in October for MODD1 with the commercial pilot for MODD1 to follow immediately thereafter.”
